Abstract
Apoptosis is the foremost method of cell death in bioreactors and can be caused by nutrient limitation, toxin accumulation, and growth factor withdrawal. By delaying the onset of this form of programmed cell death, one can achieve longer sustained viabilities in culture, thereby increasing product yield. Described here is a genetic-based, step-by-step method to generate an apoptosis-resistant cell line. This cell line, then, can be used as a platform for biotherapeutic protein production. The key steps include antiapoptotic transgene selection and transfection followed by clonal isolation and screening. With the proper screening methods, one can obtain a robust cell line that resists the harsh conditions of late-stage and/or high-density culture.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DePalma, A. (2008) Strengthening mammalian cell culture. Genetic Engineering & Biotechnol. News. 28.
Arden, N. and Betenbaugh, M.J. (2004) Life and death in mammalian cell culture: strategies for apoptosis inhibition. Trends Biotechnol. 22, 174–180.
Chiang, G.G. and Sisk, W.P. (2005) Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells. Biotechnol. Bioeng. 91, 779–792.
Nivitchanyong, T., Martinez, A., Ishaque, A., Murphy, J.E., Konstantinov, K., Betenbaugh, M., and Thrift, J. (2007) Anti-apoptotic genes Aven and E1B-19 K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture. Biotechnol. Bioeng. 98, 825–841.
Kim, Y.G. and Lee, G.M. (2009) Bcl-xL overexpression does not enhance specific erythropoietin productivity of recombinant CHO cells grown at 33 degrees C and 37 degrees C. Biotechnol. Prog. 25, 252–256.
Dorai, H., Nemeth, J., Cammaart, E., Wang, Y., Tang, Q., Magill, A., Lewis, M.J., Raju, T.S., Picha, K., O’Neil, K., Ganguly, S., and Moore, G. (2009) Development of mammalian production cell lines expressing CNTO736, a glucagon like peptide-1-MIMETIBODYTM: Factors that influence productivity and product quality. Biotechnol. Bioeng. 103, 162–176.
Sauerwald, T.M., Figueroa Jr., B., Hardwick, J.M., Betenbaugh, M.J. and Oyler, G.A. (2006) Combining caspase and mitochondrial dysfunction inhibitors of apoptosis to limit cell death in mammalian cell culture. Biotechnol. Bioeng. 94, 362–372.
Ishaque, A., and M. Al-Rubeai. (2007). Measurement of apoptosis in cell culture, in Methods in Biotechnology, Animal Cell Biotechnology (Ralf Portner, ed.) Human Press, Totowa.
Figueroa Jr., B., Ailor, E., Osborne, S., Hardwick, J.M., Reff, M., and Betenbaugh, M.J. (2006) Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19 K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells. Biotechnol. Bioeng. 97, 877–892.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Zustiak, M.P., Dorai, H., Betenbaugh, M.J., Sauerwald, T.M. (2012). Controlling Apoptosis to Optimize Yields of Proteins from Mammalian Cells. In: Hartley, J. (eds) Protein Expression in Mammalian Cells. Methods in Molecular Biology, vol 801. Humana Press. https://doi.org/10.1007/978-1-61779-352-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-61779-352-3_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-351-6
Online ISBN: 978-1-61779-352-3
eBook Packages: Springer Protocols